Asian Annals Click here to go to Medistim website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Vichai Benjacholamas
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Benjacholamas, V.
Right arrow Articles by Lertsapcharoen, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benjacholamas, V.
Right arrow Articles by Lertsapcharoen, P.
Asian Cardiovasc Thorac Ann 2008;16:189-193
© 2008 Asia Publishing EXchange Ltd


ORIGINAL CONTRIBUTIONS

Bicuspidized Pulmonary Homograft for Truncus Arteriosus Repair

Vichai Benjacholamas, MD, Jule Namchaisiri, MD, Apichai Khongphatthanayothin, MD1, Pornthep Lertsapcharoen, MD1

Cardiothoracic Unit, Department of Surgery
1 Cardiac Unit, Department of Pediatrics, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand

For reprint information contact: Vichai Benjacholamas, MD, Tel: 66 2 256 4944, Fax: 66 2 256 4974, Email: vichaicu{at}hotmail.com, Department of Surgery, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Rama IV Road, Pratumwan, Bangkok 10330, Thailand.

Primary repair is preferable to palliation in infants with truncus arteriosus. At our institute, an appropriately small homograft valved conduit is not available for every patient; a bicuspidized pulmonary valve homograft is an alternative. Between December 1996 and August 2005, 24 patients aged 28 days to 21 months with truncus arteriosus underwent primary repair with a homograft valved conduit; bicuspidized homografts were used in 15 of them. In the 18 (75%) patients who survived to hospital discharge, 5-year survival was 94% (75% for tricuspid homografts and 100% for bicuspidized homografts, which was not significantly different). Freedom from reoperation or balloon angioplasty in all 18 survivors was 89% at 5 years. Freedom from reoperation in tricuspid and bicuspidized homograft groups at 5 years was 67% and 100%, respectively; the difference was not statistically significant. Bicuspidized homografts worked as well as tricuspid conduits in the intermediate term. The remodeled homografts showed excellent hemodynamic characteristics and appear to be a reasonable alternative when an appropriate size of valved homograft is unavailable.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by the Asia Publishing EXchange Ltd.